Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: A role in depression

Biological Psychiatry

Volumn 54, Issue 10, 2003, Pages 994-1005

  Eisch, Amelia J ^a   Bolaños, Carlos A ^a   De Wit, Joris ^b   Simonak, Ryan D ^c   Pudiak, Cindy M ^d   Barrot, Michel ^a   Verhaagen, Joost ^b   Nestler, Eric J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^c RICE UNIVERSITY   (United States)

^d JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Adeno associated virus; Brain derived neurotrophic factor; Forced swim test; Nucleus accumbens; Tyrosine kinase receptor B; Ventral tegmental area

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; ISOENZYME; PHOSPHOTRANSFERASE; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DEPRESSION; EMBRYO; ENZYME DEFICIENCY; FORCED SWIMMING TEST; GENETIC CODE; HUMAN; HUMAN CELL; IMMOBILIZATION; INFUSION; INJECTION; LATENT PERIOD; LOCOMOTION; MALE; MESENCEPHALON; NONHUMAN; NUCLEUS ACCUMBENS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PSYCHOLOGIC TEST; RAT; SIGNAL TRANSDUCTION; VENTRAL TEGMENTUM;

EID: 0242559031     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2003.08.003     Document Type: Article

References (106)

1. Alderson R.F., Curtis R., Alterman A.L., Lindsay R.M., DiStefano P.S. Truncated TrkB mediates the endocytosis and release of BDNF and neurotrophin-4/ 5 by rat astrocytes and Schwann cells in vitro. Brain Res. 871:2000;210-222.
2. Altar C.A. Neurotrophins and depression. Trends Pharmacol Sci. 20:1999;59-61.
3. Altar C.A., Boylan C.B., Fritsche M., Jackson C., Hyman C., Lindsay R.M. The neurotrophins NT-4/5 and BDNF augment serotonin, dopamine, and GABAergic systems during behaviorally effective infusions to the substantia nigra. Exp Neurol. 130:1994;31-40.
4. Altar C.A., Boylan C.B., Jackson C., Hershenson S., Miller J., Wiegand S.J., et al. Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo. Proc Natl Acad Sci U S A. 89:1992;11347-11351.
5. Altar C.A., Cai N., Bliven T., Juhasz M., Conner J.M., Acheson A.L., et al. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature. 389:1997;856-860.
6. Altar C.A., Siuciak J.A., Wright P., Ip N.Y., Lindsay R.M., Wiegand S.J. In situ hybridization of trkB and trkC receptor mRNA in rat forebrain and association with high-affinity binding of [125I]BDNF [125I]NT-4/5 and [125I]NT-3. Eur J Neurosci. 6:1994;1389-1405.
7. Anderson K.D., Alderson R.F., Altar C.A., DiStefano P.S., Corcoran T.L., Lindsay R.M., Wiegand S.J. Differential distribution of exogenous BDNF, NGF, and NT-3 in the brain corresponds to the relative abundance and distribution of high-affinity and low-affinity neurotrophin receptors. J Comp Neurol. 357:1995;296-317.
8. Armanini M.P., McMahon S.B., Sutherland J., Shelton D.L., Phillips H.S. Truncated and catalytic isoforms of trkB are co-expressed in neurons of rat and mouse CNS. Eur J Neurosci. 7:1995;1403-1409.
9. Barrot M., Olivier J.D., Perrotti L.I., DiLeone R.J., Berton O., Eisch A.J., et al. CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc Natl Acad Sci U S A. 99:2002;11435-11440.
10. Bassareo V., Di Chiara G. Differential responsiveness of dopamine transmission to food-stimuli in nucleus accumbens shell/core compartments. Neuroscience. 89:1999;637-641.
11. Beck K.D., Lamballe F., Klein R., Barbacid M., Schauwecker P.E., McNeill T.H., et al. Induction of noncatalytic TrkB neurotrophin receptors during axonal sprouting in the adult hippocampus. J Neurosci. 13:1993;4001-4014.
12. Berhow M.T., Hiroi N., Nestler E.J. Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J Neurosci. 16:1996;4707-4715.
13. Berhow M.T., Russell D.S., Terwilliger R.Z., Beitner-Johnson D., Self D.W., Lindsay R.M., Nestler E.J. Influence of neurotrophic factors on morphine- and cocaine-induced biochemical changes in the mesolimbic dopamine system. Neuroscience. 68:1995;969-979.
14. Biffo S., Offenhauser N., Carter B.D., Barde Y.A. Selective binding and internalisation by truncated receptors restrict the availability of BDNF during development. Development. 121:1995;2461-2470.
15. Bremner J.D., Narayan M., Anderson E.R., Staib L.H., Miller H.L., Charney D.S. Hippocampal volume reduction in major depression. Am J Psychiatry. 157:2000;115-1158.
16. Brown A.S., Gershon S. Dopamine and depression. J Neural Transm Gen Sect. 91:1993;75-109.
17. Carlezon W.A. Jr, Thome J., Olson V.G., Lane-Ladd S.B., Brodkin E.S., Hiroi N., et al. Regulation of cocaine reward by CREB. Science. 282:1998;2272-2275.
18. Carlezon W.A., Pliakas A.M., Parow A.M., Detke M.J., Cohen B.M., Renshaw P.F. Antidepressant-like effects of cytidine in the forced swim test in rats. Biol Psychiatry. 51:2002;882-889.
19. Ceccatelli S., Ernfors P., Villar M.J., Persson H., Hokfelt T. Expanded distribution of mRNA for nerve growth factor, brain-derived neurotrophic factor, and neurotrophin 3 in the rat brain after colchicine treatment. Proc Natl Acad Sci U S A. 88:1991;10352-10356.
20. Celada P., Siuciak J.A., Tran T.M., Altar C.A., Tepper J.M. Local infusion of brain-derived neurotrophic factor modifies the firing pattern of dorsal raphe serotonergic neurons. Brain Res. 712:1996;293-298.
21. Cervo L., Rossi C., Tatarczynska E., Samanin R. Antidepressant-like effect of neurotensin administered in the ventral tegmental area in the forced swimming test. Psychopharmacology (Berl). 109:1992;369-372.
22. Conner J.M., Lauterborn J.C., Yan Q., Gall C.M., Varon S. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS Evidence for anterograde axonal transport . J Neurosci. 17:1997;2295-2313.
23. Costantini L.C., Feinstein S.C., Radeke M.J., Snyder-Keller A. Compartmental expression of trkB receptor protein in the developing striatum. Neuroscience. 89:1999;505-513.
24. Croll S.D., Chesnutt C.R., Rudge J.S., Acheson A., Ryan T.E., Siuciak J.A., et al. Co-infusion with a TrkB-Fc receptor body carrier enhances BDNF distribution in the adult rat brain. Exp Neurol. 152:1998;20-33.
25. D'Aquila P.S., Peana A.T., Carboni V., Serra G. Different effect of desipramine on locomotor activity in quinpirole-treated rats after repeated restraint and chronic mild stress. J Psychopharmacol. 14:2000;347-352.
26. Detke M.J., Johnson J., Lucki I. Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression. Exp Clin Psychopharmacol. 5:1997;107-112.
27. Detke M.J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl). 121:1995;66-72.
28. Di Chiara G., Loddo P., Tanda G. Reciprocal changes in prefrontal and limbic dopamine responsiveness to aversive and rewarding stimuli after chronic mild stress Implications for the psychobiology of depression . Biol Psychiatry. 46:1999;1624-1633.
29. Donello J.E., Loeb J.E., Hope T.J. Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element. J Virol. 72:1998;5085-5092.
30. Dorsey S.G., Bambrick L.L., Balice-Gordon R.J., Krueger B.K. Failure of brain-derived neurotrophic factor-dependent neuron survival in mouse trisomy 16. J Neurosci. 22:2002;2571-2578.
31. D'Sa C., Duman R.S. Antidepressants and neuroplasticity. Bipolar Disord. 4:2002;183-194.
32. Dziedzicka-Wasylewska M., Rogoz R. The effect of prolonged treatment with imipramine and electroconvulsive shock on the levels of endogenous enkephalins in the nucleus accumbens and the ventral tegmentum of the rat. J Neural Transm Gen Sect. 102:1995;221-228.
33. Eide F.F., Vining E.R., Eide B.L., Zang K., Wang X.Y., Reichardt L.F. Naturally occurring truncated trkB receptors have dominant inhibitory effects on brain-derived neurotrophic factor signaling. J Neurosci. 16:1996;3123-3129.
34. Eisch A.J., Barrot M., Schad C.A., Self D.W., Nestler E.J. Opiates inhibit neurogenesis in the adult rat hippocampus. Proc Natl Acad Sci U S A. 97:2000;7579-7584.
35. Ernfors P., Lee K.F., Jaenisch R. Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature. 368:1994;147-150.
36. Everitt B.J., Parkinson J.A., Olmstead M.C., Arroyo M., Robledo P., Robbins T.W. Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems. Ann N Y Acad Sci. 877:1999;412-438.
37. Fawcett J.P., Bamji S.X., Causing C.G., Aloyz R., Ase A.R., Reader T.A., et al. Functional evidence that BDNF is an anterograde neuronal trophic factor in the CNS. J Neurosci. 18:1998;2808-2821.
38. Frisen J., Verge V.M., Fried K., Risling M., Persson H., Trotter J., et al. Characterization of glial trkB receptors Differential response to injury in the central and peripheral nervous systems . Proc Natl Acad Sci U S A. 90:1993;4971-4975.
39. Furukawa S., Sugihara Y., Iwasaki F., Fukumitsu H., Nitta A., Nomoto H., Furukawa Y. Brain-derived neurotrophic factor-like immunoreactivity in the adult rat central nervous system predominantly distributed in neurons with substantial amounts of brain-derived neurotrophic factor messenger RNA or responsiveness to brain-derived neurotrophic factor. Neuroscience. 82:1998;653-670.
40. Gambarana C., Scheggi S., Tagliamonte A., Tolu P., De Montis M.G. Animal models for the study of antidepressant activity. Brain Res Brain Res Protoc. 7:2001;11-20.
41. Gambarana C., Tolu P.L., Masi F., Rinaldi M., Giachetti D., Morazzoni P., De Montis M.G. A study of the antidepressant activity of Hypericum perforatum on animal models. Pharmacopsychiatry. 34:2001;S42-S44.
42. Genedani S., Saltini S., Benelli A., Filaferro M., Bertolini A. Influence of SAMe on the modifications of brain polyamine levels in an animal model of depression. Neuroreport. 12:2001;3939-3942.
43. Ghosh A., Carnahan J., Greenberg M.E. Requirement for BDNF in activity-dependent survival of cortical neurons. Science. 263:1994;1618-1623.
44. Gonzalez M., Ruggiero F.P., Chang Q., Shi Y.J., Rich M.M., Kraner S., Balice-Gordon R.J. Disruption of Trkb-mediated signaling induces disassembly of postsynaptic receptor clusters at neuromuscular junctions. Neuron. 24:1999;567-583. [comment].
45. Grimm D., Kern A., Rittner K., Kleinschmidt J.A. Novel tools for production and purification of recombinant adenoassociated virus vectors. Hum Gene Ther. 9:1998;2745-2760.
46. Grimm J.W., Lu L., Hayashi T., Hope B.T., Su T.P., Shaham Y. Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine Implications for incubation of cocaine craving . J Neurosci. I:2003;742-747.
47. Guillin O., Diaz J., Carroll P., Griffon N., Schwartz J.C., Sokoloff P. BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature. 411:2001;86-89.
48. Haapasalo A., Koponen E., Hoppe E., Wong G., Castren E. Truncated trkB. T1 is dominant negative inhibitor of trkB.TK+-mediated cell survival. Biochem Biophys Res Commun. 280:2001;1352-1358.
49. Haapasalo A., Saarelainen T., Moshnyakov M., Arumae U., Kiema T.R., Saarma M., et al. Expression of the naturally occurring truncated trkB neurotrophin receptor induces outgrowth of filopodia and processes in neuroblastoma cells. Oncogene. 18:1999;1285-1296.
50. Hermens W.T., ter Brake O., Dijkhuizen P.A., Sonnemans M.A., Grimm D., Kleinschmidt J.A., Verhaagen J. Purification of recombinant adeno-associated virus by iodixanol gradient ultracentrifugation allows rapid and reproducible preparation of vector stocks for gene transfer in the nervous system. Hum Gene Ther. 10:1999;1885-1891.
51. Hofer M., Pagliusi S.R., Hohn A., Leibrock J., Barde Y.A. Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J. 9:1990;2459-2464.
52. Horger B.A., Iyasere C.A., Berhow M.T., Messer C.J., Nestler E.J., Taylor J.R. Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J Neurosci. 19:1999;4110-4122.
53. Hung H.C., Lee E.H. The mesolimbic dopaminergic pathway is more resistant than the nigrostriatal dopaminergic pathway to MPTP and MPP+ toxicity Role of BDNF gene expression . Brain Res Mol Brain Res. 41:1996;14-26.
54. Jones K.R., Farinas I., Backus C., Reichardt L.F. Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell. 76:1994;989-999.
55. Keck M.E., Welt T., Muller M.B., Erhardt A., Ohl F., Toschi N., et al. Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system. Neuropharmacology. 43:2002;101-109.
56. Klein R., Conway D., Parada L.F., Barbacid M. The trkB tyrosine protein kinase gene codes for a second neurogenic receptor that lacks the catalytic kinase domain. Cell. 61:1990;647-656.
57. Klein R., Martin-Zanca D., Barbacid M., Parada L.F. Expression of the tyrosine kinase receptor gene trkB is confined to the murine embryonic and adult nervous system. Development. 109:1990;845-850.
58. Klein R., Smeyne R.J., Wurst W., Long L.K., Auerbach B.A., Joyner A.L., Barbacid M. Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death. Cell. 75:1993;113-122.
59. Koob G.F. Circuits, drugs, and drug addiction. Adv Pharmacol. 42:1998;978-982.
60. Kram M.L., Kramer G.L., Ronan P.J., Steciuk M., Petty F. Dopamine receptors and learned helplessness in the rat An autoradiographic study . Prog Neuropsychopharmacol Biol Psychiatry. 26:2002;639-645.
61. Kryl D., Yacoubian T., Haapasalo A., Castren E., Lo D., Barker P.A. Subcellular localization of full-length and truncated Trk receptor isoforms in polarized neurons and epithelial cells. J Neurosci. 19:1999;5823-5833.
62. Lapchak P.A., Hefti F. BDNF and NGF treatment in lesioned rats Effects on cholinergic function and weight gain . Neuroreport. 3:1992;405-408.
63. Linner L., Endersz H., Ohman D., Bengtsson F., Schalling M., Svensson T.H. Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex. J Pharmacol Exp Ther. 297:2001;540-546.
64. Loeb J.E., Cordier W.S., Harris M.E., Weitzman M.D., Hope T.J. Enhanced expression of transgenes from adeno-associated virus vectors with the woodchuck hepatitis virus posttranscriptional regulatory element Implications for gene therapy . Hum Gene Ther. 10:1999;2295-2305.
65. Lucki I. The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol. 8:1997;523-532.
66. MacQueen G.M., Ramakrishnan K., Croll S.D., Siuciak J.A., Yu G., Young L.T., Fahnestock M. Performance of heterozygous brain-derived neurotrophic factor knockout mice on behavioral analogues of anxiety, nociception, and depression. Behav Neurosci. 115:2001;1145-1153.
67. Mamounas L.A., Altar C.A., Blue M.E., Kaplan D.R., Tessarollo L., Lyons W.E. BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. J Neurosci. 20:2000;771-782.
68. Martin-Iverson M.T., Todd K.G., Altar C.A. Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors Interactions with amphetamine . J Neurosci. 14:1994;1262-1270.
69. Mayberg H.S. Modulating limbic-cortical circuits in depression Targets of antidepressant treatments . Semin Clin Neuropsychiatry. 7:2002;255-268.
70. Merlio J.P., Ernfors P., Jaber M., Persson H. Molecular cloning of rat trkC and distribution of cells expressing messenger RNAs for members of the trk family in the rat central nervous system. Neuroscience. 51:1992;513-532.
71. Mizuno M., Yamada K., Olariu A., Nawa H., Nabeshima T. Involvement of brain-derived neurotrophic factor in spatial memory formation and maintenance in a radial arm maze test in rats. J Neurosci. 20:2000;7116-7121.
72. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron. 34:2002;13-25.
73. Nibuya M., Morinobu S., Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci. 15:1995;7539-7547.
74. Nibuya M., Nestler E.J., Duman R.S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci. 16:1996;2365-2372.
75. Ninkina N., Adu J., Fischer A., Pinon L.G., Buchman V.L., Davies A.M. Expression and function of TrkB variants in developing sensory neurons. EMBO J. 15:1996;6385-6393.
76. Ortiz J., Fitzgerald L.W., Lane S., Terwilliger R., Nestler E.J. Biochemical adaptations in the mesolimbic dopamine system in response to repeated stress. Neuropsychopharmacology. 14:1996;443-452.
77. Pallis E., Thermos K., Spyraki C. Chronic desipramine treatment selectively potentiates somatostatin-induced dopamine release in the nucleus accumbens. Eur J Neurosci. 14:2001;763-767.
78. Pelleymounter M.A., Cullen M.J., Wellman C.L. Characteristics of BDNF-induced weight loss. Exp Neurol. 131:1995;229-238.
79. Pierce R.C., Pierce-Bancroft A.F., Prasad B.M. Neurotrophin-3 contributes to the initiation of behavioral sensitization to cocaine by activating the Ras/Mitogen-activated protein kinase signal transduction cascade. J Neurosci. 19:1999;8685-8695.
80. Pliakas A.M., Carlson R.R., Neve R.L., Konradi C., Nestler E.J., Carlezon W.A. Jr. Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J Neurosci. 21:2001;7397-7403.
81. Porsolt R.D., Anton G., Blavet N., Jalfre M. Behavioural despair in rats A new model sensitive to antidepressant treatments . Eur J Pharmacol. 47:1978;379-391.
82. Porsolt R.D., Bertin A., Jalfre M. "Behavioural despair" in rats and mice Strain differences and the effects of imipramine . Eur J Pharmacol. 51:1978;291-294.
83. Rosin D.L., Melia K., Knorr A.M., Nestler E.J., Roth R.H., Duman R.S. Chronic imipramine administration alters the activity and phosphorylation state of tyrosine hydroxylase in dopaminergic regions of rat brain. Neuropsychopharmacology. 12:1995;113-121.
84. Rubio N. Mouse astrocytes store and deliver brain-derived neurotrophic factor using the non-catalytic gp95trkB receptor. Eur J Neurosci. 9:1997;1847-1853.
85. Saarelainen T., Hendolin P., Lucas G., Koponen E., Sairanen M., MacDonald E., et al. Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J Neurosci. 23:2003;349-357.
86. Sauer H., Fischer W., Nikkhah G., Wiegand S.J., Brundin P., Lindsay R.M., Bjorklund A. Brain-derived neurotrophic factor enhances function rather than survival of intrastriatal dopamine cell-rich grafts. Brain Res. 626:1993;37-44.
87. Schwartz K., Yadid G., Weizman A., Rehavi M. Decreased limbic vesicular monoamine transporter 2 in a genetic rat model of depression. Brain Res. 965:2003;174-179.
88. Serra G., Collu M., D'Aquila P.S., Gessa G.L. Role of the mesolimbic dopamine system in the mechanism of action of antidepressants. Pharmacol Toxicol. 71:1992;72-85.
89. Sheline Y.I., Mayberg H.S. Hippocampal atrophy in major depression A result of depression-induced neurotoxicity? Mol Psychiatry. 1:1996;298-299.
90. Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., Duman R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci. 22:2002;3251-3261.
91. Shumake J., Edwards E., Gonzalez-Lima F. Opposite metabolic changes in the habenula and ventral tegmental area of a genetic model of helpless behavior. Brain Res. 963:2003;274-281.
92. Siuciak J.A., Boylan C., Fritsche M., Altar C.A., Lindsay R.M. BDNF increases monoaminergic activity in rat brain following intracerebroventricular or intraparenchymal administration. Brain Res. 710:1996;11-20.
93. Siuciak J.A., Lewis D.R., Wiegand S.J., Lindsay R.M. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav. 56:1997;131-137.
94. Sklair-Tavron L., Nestler E.J. Opposing effects of morphine and the neurotrophins, NT-3, NT-4, and BDNF, on locus coeruleus neurons in vitro. Brain Res. 702:1995;117-125.
95. Smith M.A., Makino S., Kvetnansky R., Post R.M. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci. 15:1995;1768-1777.
96. Smith M.A., Zhang L.X., Lyons W.E., Mamounas L.A. Anterograde transport of endogenous brain-derived neurotrophic factor in hippocampal mossy fibers. Neuroreport. 8:1997;1829-1834.
97. Tamminga C.A., Nemeroff C.B., Blakely R.D., Brady L., Carter C.S., Davis K.L., et al. Developing novel treatments for mood disorders Accelerating discovery . Biol Psychiatry. 52:2002;589-609.
98. Thome J., Sakai N., Shin K., Steffen C., Zhang Y.J., Impey S., et al. CAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci. 20:2000;4030-4036.
99. Toda S., McGinty J.F., Kalivas P.W. Repeated cocaine administration alters the expression of genes in corticolimbic circuitry after a 3-week withdrawal A DNA macroarray study . J Neurochem. 82:2002;1290-1299.
100. Weiss J.M., Bonsall R.W., Demetrikopoulos M.K., Emery M.S., West C.H. Galanin A significant role in depression? Ann N Y Acad Sci. 863:1998;364-382.
101. Wolf D.H., Numan S., Nestler E.J., Russell D.S. Regulation of phospholipase Cgamma in the mesolimbic dopamine system by chronic morphine administration. J Neurochem. 73:1999;1520-1528.
102. Yadid G., Overstreet D.H., Zangen A. Limbic dopaminergic adaptation to a stressful stimulus in a rat model of depression. Brain Res. 896:2001;43-47.
103. Yan Q., Matheson C., Sun J., Radeke M.J., Feinstein S.C., Miller J.A. Distribution of intracerebral ventricularly administered neurotrophins in rat brain and its correlation with trk receptor expression. Exp Neurol. 127:1994;23-36.
104. Yan Q., Radeke M.J., Matheson C.R., Talvenheimo J., Welcher A.A., Feinstein S.C. Immunocytochemical localization of TrkB in the central nervous system of the adult rat. [erratum appears in J Comp Neurol 1997;382:546-547] J Comp Neurol. 378:1997;135-157.
105. Zangen A., Nakash R., Overstreet D.H., Yadid G. Association between depressive behavior and absence of serotonin-dopamine interaction in the nucleus accumbens. Psychopharmacology (Berl). 155:2001;434-439.
106. Zhou X.F., Rush R.A. Endogenous brain-derived neurotrophic factor is anterogradely transported in primary sensory neurons. Neuroscience. 74:1996;945-953.